Calidi Biotherapeutics, Inc. (CLDI) is a publicly traded Healthcare sector company. As of September 8, 2026, CLDI trades at $1.36 with a market cap of $3.58M and a P/E ratio of -0.23. CLDI moved -2.17% today. Year to date, CLDI is -92.47%; over the trailing twelve months it is -94.49%. Its 52-week range spans $1.25 to $307.20. Rallies surfaces CLDI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $1.36 |
| Market Cap | $3.58M |
| P/E Ratio | -0.23 |
| EPS | $-5.95 |
| Dividend Yield | 0.00% |
| 52-Week High | $307.20 |
| 52-Week Low | $1.25 |
| Volume | 8.50K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-20.06M |
| Gross Margin | 0.00% |
CLDI analyst coverage data. Average price target: $0.00.